Paul C. Varki
SVP & General Counsel
An executive with over 20 years’ experience within the pharmaceuticals/biotech industry, Paul was most recently Senior Vice President, General Counsel, and Chief Compliance Officer at Egalet Corporation, where he built Egalet’s legal and compliance functions, led strategic regulatory and policy initiatives, supported the commercial launch of the first abuse deterrent morphine product, and successfully handled a variety of legal matters across intellectual property, corporate, and commercial areas. Paul joined Egalet from GlaxoSmithKline, where he had been assistant general counsel, providing global legal support for research and development. Prior to that role he served as senior counsel for the vaccines business unit within GSK North America and counsel for marketed products within its U.S. pharmaceuticals business. Before GSK, Paul practiced food and drug law at Reed Smith LLP, and served as regulatory counsel for the Food and Drug Administration (FDA) in the Center for Drug Evaluation and Research (CDER).